Last week, controversy over the claims over the prowess of eye drops prescribed for presbyopia (progressive loss of the near focusing ability of the eye due to ageing), led to the Central Drugs ...
The eye drops were initially approved for treating presbyopia in adults, but this approval was suspended on September 10, by the Central Drugs Standard Control Organization (CDSCO) following what ...
In India, millions of people over 40 wear reading glasses due to presbyopia, an age-related vision condition that affects near vision. With the introduction of PresVu eye drops by ENTOD ...
Entod Pharmaceuticals has unveiled PresVu, India's first eye drop developed to lessen dependence on reading glasses for those with presbyopia. Affecting people over 40, this condition hampers the ...
Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity ...
The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near objects ...
ENTOD Pharmaceuticals has recently launched PresVu eye drops, which have been approved by the Drug Controller General of India (DCGI). Marketed as a potential breakthrough for presbyopia — a ...
The recent approval of Vuity by the Food and Drug Administration marks a significant advancement in treating presbyopia, a ...
India's drug regulatory agency has approved new eye drops that can help remove reading glasses in people who have presbyopia. These new eye drops, known as PresVuand manufactured by Mumbai-based Entod ...
PresVu eye drops, developed by Entod Pharmaceuticals, were launched with considerable media attention earlier this month as a novel solution for presbyopia. Presbyopia is a condition where ...
A Place In The Sun presenter Jean Johannsson has been diagnosed with presbyopia - the gradual loss of your eyes' ability to focus on nearby objects. After being in denial about her declining ...
More severe visual symptoms among women aged 46-55 years may be attributed to menopause-related visual changes.